Unlike other cancers, in clinical specimens of non-small cell lung cancer (NSCLC), tumor cells and blood vessels are predominantly negative for CXCR3, while infiltrating immune cells show strong CXCR3 staining. Here, CXCR3 is linked to non-small cell lung carcinoma.